⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16176823 | 1.00 | — | — | |
| SCHEMBL6772032 | 1.00 | — | — | |
| SCHEMBL2185815 | 0.79 | PTGS1 (0.48) | — | |
| SCHEMBL2154512 | 0.78 | — | — | |
| SCHEMBL27604246 | 0.73 | — | — | |
| SCHEMBL330043 | 0.73 | — | — | |
| SCHEMBL360350 | 0.73 | — | — | |
| SCHEMBL3628671 | 0.73 | — | — | |
| SCHEMBL28567598 | 0.71 | PTGS1 (0.40) | — | |
| SCHEMBL170745 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12005108-B2 | Lactococcus lactis subspecies lactis isolate WFLU-12 and use thereof | PUKYONG NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2024-06-11 | — | — | US | claimed |
| CN-113769108-A | Conjugates of cysteine engineered antibodies | 伊缪诺金公司 | 2021-12-10 | — | — | CN | claimed |
| EP-3313845-A1 | CONJUGATES OF CYSTEINE ENGINEERED ANTIBODIES | ImmunoGen, Inc. (US) | 2018-05-02 | — | — | EP | claimed |
| CN-107708810-A | Conjugates of cysteine engineered antibodies | 伊缪诺金公司 | 2018-02-16 | — | — | CN | claimed |
| CN-107580604-A | Conjugate comprising cell binding agent and cytotoxic agent | 伊缪诺金公司 | 2018-01-12 | — | — | CN | claimed |
| EP-3188733-A1 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | ImmunoGen, Inc. (US) | 2017-07-12 | — | — | EP | claimed |
| WO-2017004025-A1 | CONJUGATES OF CYSTEINE ENGINEERED ANTIBODIES | IMMUNOGEN, INC. (US) | 2017-01-05 | — | — | WO | claimed |
| WO-2016036794-A1 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | IMMUNOGEN, INC. (US) | 2016-03-10 | — | — | WO | claimed |
| EP-2961435-A2 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | ImmunoGen, Inc. (US) | 2016-01-06 | — | — | EP | claimed |
| US-20150359904-A1 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | IMMUNOGEN, INC. | 2015-12-17 | — | — | US | claimed |
| WO-2014194030-A2 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | IMMUNOGEN, INC. (US) | 2014-12-04 | — | — | WO | claimed |
| WO-2014134486-A2 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | IMMUNOGEN, INC. (US) | 2014-09-04 | — | — | WO | claimed |
| WO-2014134457-A2 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | IMMUNOGEN, INC. (US) | 2014-09-04 | — | — | WO | claimed |
| CN-101983066-A | Ester-based peptide prodrugs | UNIV INDIANA RES & TECH CORP | 2011-03-02 | — | — | CN | claimed |
| US-5908768-A | EFFICIENT BIOSYNTHESIS | AJINOMOTO CO., INC. (JP) | 1999-06-01 | — | — | US | claimed |
| EP-0220537-B1 | PHARMACEUTICAL COMPOSITION CONTAINING THYMUS EXTRACT FRACTIONS | Dr. Kurt Mulli Nachf. GmbH & Co. KG (DE) | 1990-07-25 | — | — | EP | claimed |
| US-4826680-A | AUTOIMMUNE DISEASES | DR. KURT MULLI NACHF. GMBH & CO. KG (DE) | 1989-05-02 | — | — | US | claimed |
| EP-4746922-A2 | INTERLEUKIN-13 RECEPTOR SUBUNIT ALPHA-2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF | Exelixis, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-1987005633-A1 | METHOD FOR DETECTION OF PERIODONTAL DISEASE | XYTRONYX, INC. (US) | 1987-09-24 | — | — | WO | disclosed |
| EP-0151536-A2 | Method and kit for determining periodontal disease | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1985-08-14 | — | — | EP | disclosed |